Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Population pharmacokinetics of lamotrigine in elderly patients.

Punyawudho B, Ramsay RE, Macias FM, Rowan AJ, Collins JF, Brundage RC, Birnbaum AK.

J Clin Pharmacol. 2008 Apr;48(4):455-63. doi: 10.1177/0091270007313391. Epub 2008 Feb 22.

PMID:
18296554
3.

Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy.

Grasela TH, Fiedler-Kelly J, Cox E, Womble GP, Risner ME, Chen C.

J Clin Pharmacol. 1999 Apr;39(4):373-84.

PMID:
10197296
4.

Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients.

Singkham N, Towanabut S, Lertkachatarn S, Punyawudho B.

Eur J Clin Pharmacol. 2013 Jun;69(6):1285-91. doi: 10.1007/s00228-012-1449-5. Epub 2012 Dec 21.

PMID:
23263737
5.

Population pharmacokinetics of lamotrigine in patients with epilepsy.

Milovanovic JR, Jankovic SM.

Int J Clin Pharmacol Ther. 2009 Dec;47(12):752-60.

PMID:
19954714
6.

Population pharmacokinetics of carbamazepine in elderly patients.

Punyawudho B, Ramsay ER, Brundage RC, Macias FM, Collins JF, Birnbaum AK.

Ther Drug Monit. 2012 Apr;34(2):176-81. doi: 10.1097/FTD.0b013e31824d6a4e.

7.

Population pharmacokinetics of lamotrigine.

Chan V, Morris RG, Ilett KF, Tett SE.

Ther Drug Monit. 2001 Dec;23(6):630-5.

PMID:
11802095
8.

Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.

Milosheska D, Lorber B, Vovk T, Kastelic M, Dolžan V, Grabnar I.

Br J Clin Pharmacol. 2016 Aug;82(2):399-411. doi: 10.1111/bcp.12984. Epub 2016 May 29.

9.

Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy.

Jawad S, Yuen WC, Peck AW, Hamilton MJ, Oxley JR, Richens A.

Epilepsy Res. 1987 May;1(3):194-201.

PMID:
3504397
10.

Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.

Theis JG, Sidhu J, Palmer J, Job S, Bullman J, Ascher J.

Neuropsychopharmacology. 2005 Dec;30(12):2269-74.

11.

Pharmacokinetics of lamotrigine in children in the absence of other antiepileptic drugs.

Chen C, Casale EJ, Duncan B, Culverhouse EH, Gilman J.

Pharmacotherapy. 1999 Apr;19(4):437-41.

PMID:
10212015
12.

Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.

Gidal BE, Anderson GD, Rutecki PR, Shaw R, Lanning A.

Epilepsy Res. 2000 Nov;42(1):23-31.

PMID:
10996503
13.

Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy.

Ramsay RE, Pellock JM, Garnett WR, Sanchez RM, Valakas AM, Wargin WA, Lai AA, Hubbell J, Chern WH, Allsup T, et al.

Epilepsy Res. 1991 Nov-Dec;10(2-3):191-200.

PMID:
1817959
14.

Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.

Rivas N, Buelga DS, Elger CE, Santos-Borbujo J, Otero MJ, Domínguez-Gil A, García MJ.

Ther Drug Monit. 2008 Aug;30(4):483-9. doi: 10.1097/FTD.0b013e31817fd4d4.

PMID:
18641550
15.

The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.

Wegner I, Wilhelm AJ, Sander JW, Lindhout D.

Epilepsy Behav. 2013 Oct;29(1):217-21. doi: 10.1016/j.yebeh.2013.07.016. Epub 2013 Aug 29.

PMID:
23995050
16.
17.

Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.

Zhou H, Mayer PR, Wajdula J, Fatenejad S.

J Clin Pharmacol. 2004 Nov;44(11):1235-43.

PMID:
15496641
18.

Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics.

Brzaković BB, Vezmar Kovačević SD, Vučićević KM, Miljković BR, Martinović ZJ, Pokrajac MV, Prostran MŠ.

J Clin Pharm Ther. 2012 Dec;37(6):693-7. doi: 10.1111/j.1365-2710.2012.01351.x. Epub 2012 May 14.

PMID:
22583007
19.

Factors influencing the population pharmacokinetic parameters of phenytoin in adult epileptic patients in South Africa.

Valodia P, Seymour MA, Miller R, McFadyen ML, Folb PI.

Ther Drug Monit. 1999 Feb;21(1):57-62.

PMID:
10051055
20.

Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service.

Reimers A, Skogvoll E, Sund JK, Spigset O.

J Clin Psychopharmacol. 2005 Aug;25(4):342-8.

PMID:
16012277

Supplemental Content

Support Center